Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
(Reuters) -Denmark’s Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million…
(Reuters) -Denmark’s Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million…
MediLink Therapeutics Ltd. has hired China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley for a planned initial…
Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor. www.marketwatch.com #Vivek…